A comprehensive approach is necessary for navigating the highly heterogeneous nature of leukemia across different age ...
Clinical Trials Arena on MSN
Rivus Pharmaceuticals begins patient dosing in Phase II AMPLIFY trial
The trial will enrol around 180 adults with F2/F3 MASH.
Acute myeloid leukemia (AML) has a poor prognosis, especially in elderly and relapsed/refractory patients, with 5‑year ...
In this webinar, Zivjena Vucetic will discuss how single-cell sequencing improves measurable residual disease detection (MRD) ...
SIERRA VISTA — After a futile federal probe of the childhood leukemia cluster in Sierra Vista, fear of the disease is growing, not waning, prompting a new state study to find out if adults here are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results